FAM98B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.17357292959286E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.78888065156025E-12 |
Normal-vs-Stage2 |
1.78510000004017E-07 |
Normal-vs-Stage3 |
1.51492000000086E-05 |
Normal-vs-Stage4 |
1.27340000000142E-06 |
Stage1-vs-Stage2 |
9.836600E-01 |
Stage1-vs-Stage3 |
6.218400E-01 |
Stage1-vs-Stage4 |
7.253400E-01 |
Stage2-vs-Stage3 |
6.775000E-01 |
Stage2-vs-Stage4 |
6.627800E-01 |
Stage3-vs-Stage4 |
4.718000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.72144587052526E-12 |
Normal-vs-AfricanAmerican |
1.15210000428689E-08 |
Normal-vs-Asian |
6.965200E-04 |
Caucasian-vs-AfricanAmerican |
7.996400E-01 |
Caucasian-vs-Asian |
8.990800E-01 |
AfricanAmerican-vs-Asian |
8.338200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.77469150486331E-12 |
Normal-vs-Female |
4.803200E-04 |
Male-vs-Female |
4.560000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.49729999802062E-08 |
Normal-vs-Extreme_Weight |
2.48845388739483E-12 |
Normal-vs-Obese |
2.88999999487061E-08 |
Normal-vs-Extreme_Obese |
1.369820E-02 |
Normal_Weight-vs-Extreme_Weight |
3.166400E-01 |
Normal_Weight-vs-Obese |
5.117600E-01 |
Normal_Weight-vs-Extreme_Obese |
9.321800E-01 |
Extreme_Weight-vs-Obese |
5.935800E-02 |
Extreme_Weight-vs-Extreme_Obese |
6.394600E-01 |
Obese-vs-Extreme_Obese |
6.349800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.57389999999791E-05 |
Normal-vs-Age(41-60Yrs) |
1.78509995674148E-09 |
Normal-vs-Age(61-80Yrs) |
3.32456284724003E-12 |
Normal-vs-Age(81-100Yrs) |
5.54610000147449E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.677400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.244800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.427400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.811010E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.529000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.008400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
9.14157638476354E-13 |
Normal-VS-Type2 PRCC |
1.41629996619486E-09 |
Normal-VS-KIRP CIMP |
1.606410E-04 |
Normal-VS-Unclassified PRCC |
2.24620000044418E-07 |
Type1 PRCC-VS-Type2 PRCC |
5.010600E-01 |
Type1 PRCC-VS-KIRP CIMP |
4.710600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
5.399400E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.053000E-01 |
Type2 PRCC-VS-Unclassified PRCC |
9.427800E-01 |
KIRP CIMP-VS-Unclassified PRCC |
7.168200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.80218079243377E-12 |
Normal-vs-N1 |
2.635500E-04 |
Normal-vs-N2 |
1.376300E-04 |
N0-vs-N1 |
1.040770E-01 |
N0-vs-N2 |
7.244600E-01 |
N1-vs-N2 |
3.638800E-01 |
|
|